Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Placebo-Controlled Study of the Alternative Therapy S-Adenosyl-L-Methionine (SAMe) vs Escitalopram in Major Depressive Disorder (MDD)

NCT00101452 is registered in ClinicalTrials.gov with Maurizio Fava, MD as lead sponsor.

NCT NCT00101452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00101452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Placebo-Controlled Study of the Alternative Therapy S-Adenosyl-L-Methionine (SAMe) vs Escitalopram in Major Depressive Disorder (MDD)
Lead sponsor
Maurizio Fava, MD
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2005
Completion date
June 30, 2010
Enrollment
199 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

depression